Pipeline

Hemostasis

Hemophilia A or B w Inhibitors - ToB
Phase 3
     
FVIID/Glanzmann/Hemlibra - ToB
Phase 1/2
     
Drug Candidate
Indication
Research
Preclinical
Phase 1/2
Phase 2
Phase 3

Complement

C3 degrader for Dry AMD
Preclinical
     
Enhanced CFI
Preclinical
     
Preclinical
     
Preclinical
     

Hemostasis

Hemophilia B
Phase 2
     
Hemophilia B FIX Gene Therapy
Preclinical